Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2019-06-01 (6 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: RUEIL-MALMAISON (92500), Hauts-de-Seine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PISCOPO PHARMA : revenue, balance sheet and financial ratios
PISCOPO PHARMA is a French company
founded 6 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in RUEIL-MALMAISON (92500),
this company of category PME
shows in 2025 a net income negative of -87 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PISCOPO PHARMA (SIREN 850948035)
Indicator
2025
2024
2023
2022
2021
2020
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
-87 292 €
-24 735 €
23 638 €
457 234 €
356 610 €
94 943 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PISCOPO PHARMA records a net loss of 87 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-87 292 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 54%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 48%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
54.377%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.107%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Debt ratio
663.058
95.724
37.619
53.915
46.366
54.377
Financial autonomy
10.19
37.126
59.102
50.713
53.564
48.107
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
54.382025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average+8 pts over 3 years
In 2025, the debt ratio of PISCOPO PHARMA (54.38) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.11%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Average-10 pts over 3 years
In 2025, the financial autonomy of PISCOPO PHARMA (48.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 178.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
178.851
Liquidity indicators evolution PISCOPO PHARMA
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
2024
2025
Liquidity ratio
229.946
200.393
280.008
233.045
209.99
178.851
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
178.852025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Average-15 pts over 3 years
In 2025, the liquidity ratio of PISCOPO PHARMA (178.85) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PISCOPO PHARMA in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PISCOPO PHARMA with other companies in the same sector:
The revenue of PISCOPO PHARMA is not publicly disclosed (confidential accounts filed with INPI).
Is PISCOPO PHARMA profitable?
PISCOPO PHARMA recorded a net loss in 2025.
Where is the headquarters of PISCOPO PHARMA ?
The headquarters of PISCOPO PHARMA is located in RUEIL-MALMAISON (92500), in the department Hauts-de-Seine.
Where to find the tax return of PISCOPO PHARMA ?
The tax return of PISCOPO PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PISCOPO PHARMA operate?
PISCOPO PHARMA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart